Minimizing Atrial Pacing No Benefit in Sinus Node Disease: DANPACE II Posted on September 1st, 2023 by LEADconnection Post navigation Previous: Impact of RV Pacing in Heart Failure, CRT Benefit Shown in BUDAPEST-CRTNext: New data hint at “hard to beat” efficacy and safety for rotational TLE
Impact of RV Pacing in Heart Failure, CRT Benefit Shown in BUDAPEST-CRT Posted on August 31st, 2023 by LEADconnection Post navigation Previous: Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patientsNext: Minimizing Atrial Pacing No Benefit in Sinus Node Disease: DANPACE II
Class I Recall for 350,000 Medtronic Defibrillators: FDA Posted on July 19th, 2023 by LEADconnection Post navigation Previous: Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation (HEAL)Next: Preclinical cardiac perforation reduction in leadless pacing: Anupdate to the Micra leadless pacemaker delivery system